53
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Acute myeloid leukemia in the elderly: Etoposide when anthracyclins are contraindicated

, , &
Pages 401-404 | Published online: 01 Jul 2009

REFERENCES

  • Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051 —1062.
  • Baudard M, Beauchamp-Nicoud A, Delmer A, Rio B, BlancC, Marie JP et al. Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over 16-years-old. Leukemia 1999;13:1481–1490.
  • Baudard M, Marie JP, Cadiou M, Viguié F, Zittoun R. Acute myelogenous leukemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol 1994;86: 82–91.
  • Bishop JF, Lowenthal R, Joshua D, Matthews JP, Wolf MM, Cooper IA. Etoposide in leukemia. Cancer 1991;67\(Suppl. 1):285— 291.
  • Grimwalde D, Walker H, Oliver F, Wheatley K, Harrison H, Rees J et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322–2333.
  • Rowe JM. Treatment of acute myelogenous leukemia in older adults. Leukemia 2000;14:480–487.
  • Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukemia in patients over 55-years-old: a population based study of incidence, treat-ment and outcome. Leukemia 1995;9:231–237.
  • Lowenberg B, Sucieu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R et al. Mitoxantrone versus daunorubicin in induction and consolidation therapy: the value of low-dose cytarabine for maintenance remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report of the Leukemia Organization for the Research and Treatment of Cancer and the Dutch—Belgium Hemato-Oncology Cooperative Hovon Group Randomised Phase III Study ANLL9. J Chin Oncol 1998;16: 872 — 880.
  • Gryn J, Conroy J, Topolsky D, Crilley P, Kahn SB, Bulova S et al. High-dose cytosine arabinoside and etoposide in the treatment of relapsed or refractory adult leukemia. Am J Chin Oncol 1991;14:52 — 54.
  • Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K, Burnett AK, Goldstone AH. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001;98: 312–320.
  • Legrand 0, Perrot JY, Simonin G, Baudard M, Marie JP. JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia. Blood 2001;97: 502–508.
  • Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (1\4DR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood 1997;89:3323–3329.
  • Estey EH. How I treat older patients with AML. Blood 2000;96:1670 — 1673.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.